换一批Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508.
第一作者：
Yoshitoyo,Kagami
第一单位：
Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Japan. y-kagami@toyota.jaaikosei.or.jp
作者：
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);女(雌)性(Female);人类(Humans);日本(Japan);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);泼尼松(Prednisone);预后(Prognosis);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1007/s12185-012-1101-2
PMID
22661011
发布时间
2021-10-21
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
